FITC anti-mouse CD107a (LAMP-1) Antibody
- 产品名称：
- FITC anti-mouse CD107a (LAMP-1) Antibody
- 产品类别：
- 抗体
- 产品编号：
- 121605
- 产品应用：
- 121605
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- This monoclonal antibody was raised against NIH/3T3 mouse embryonic fibroblast tissue culture cell membranes. It has been mapped to the N-terminus of LAMP-1.
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
- Concentration
- 0.5 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
- Product Citations
-
- Villarreal D, et al. 2015. Vaccine. 33: 4313-4320. PubMed
- Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
- Rosenheinrich M, et al. 2015. PLoS One. 10: 0136290. PubMed
- Page N, et al. 2018. Immunity. 48:937. PubMed
- Koh CH, et al. 2020. Cancer Immunol Res. 8:698. PubMed
- Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
- Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
- Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
- Panciera T, et al. 2016. Cell Stem Cell. 19:725-737. PubMed
- Gary EN, et al. 2021. iScience. 24(7):102699. PubMed
- Goggi JL, et al. 2020. Mol Imaging Biol. 22:1392. PubMed
- Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
- Zhou D, et al. 2022. Nat Commun. 13:5174. PubMed
- Wagle MV, et al. 2021. Nat Commun. 12:2782. PubMed
- Chen Z et al. 2019. Immunity. 51(5):840-855 . PubMed
- Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
- Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
- Yan Y, et al. 2018. JCI Insight. 3. PubMed
- Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
- Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
- Zhang Y, et al. 2018. Nat Commun. 9:6. PubMed
- Klein JC, et al. 2017. Nat Commun. 8:14600. PubMed
- Nembrini C, et al. 2011. Proc Natl Acad Sci U S A. 108:E989. PubMed
- He Y, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.04.001. PubMed
- Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
- Chen Z, et al. 2021. Cell. 184(5):1262-1280.e22. PubMed
- Bransi A, et al. 2015. Cancer Immunol Res. 3: 1279 - 1288. PubMed
- Reguzova A, et al. 2020. Vaccines (Basel). 8:. PubMed
- Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
- Wolf Y, et al. 2019. Cell. 179:219. PubMed
- RRID
- AB_572006 (BioLegend Cat. No. 121605) AB_572007 (BioLegend Cat. No. 121606)
